Aurinia Pharmaceuticals
AUPH
#4850
Rank
A$3.00 B
Marketcap
A$23.37
Share price
4.71%
Change (1 day)
104.13%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): A$0.20 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of A$0.17 Billion, an increase over its 2024 earnings that were of A$17.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.20 B20.17%
2025 A$0.17 B864.64%
2024 A$17.69 M-116.44%
2023 -A$0.11 Billion-31.8%
2022 -A$0.16 Billion-39.4%
2021 -A$0.27 Billion61.9%
2020 -A$0.17 Billion-9.73%
2019 -A$0.18 Billion92.65%
2018 -A$92.5 Million36.39%
2017 -A$67.82 Million106.29%
2016 -A$32.88 Million-15.4%
2015 -A$38.86 Million65.84%
2014 -A$23.43 Million129.82%
2013 -A$10.2 Million-26.6%
2012 -A$13.89 Million
2010 -A$7.87 Million-39.22%
2009 -A$12.94 Million-43.78%
2008 -A$23.02 Million-53.19%
2007 -A$49.17 Million42.97%
2006 -A$34.4 Million-23.03%
2005 -A$44.69 Million36.1%
2004 -A$32.84 Million172.57%
2003 -A$12.05 Million484.61%
2002 -A$2.07 Million
2000 -A$9.79 Million453.81%
1999 -A$1.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
A$7.43 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-A$31.88 Million-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-A$7.91 Million-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA